TrademarkDir
LB
LIVE

Serial Number

79254778

Owner

Legend Biotech USA Inc.

Filing Date

Sep 26, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LB Trademark

Serial Number: 79254778 • Registration: 5887781

LB is a trademark filed by Legend Biotech USA Inc. on September 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Legend Biotech USA Inc.

2101 Cottontail Lane

Entity Type: 99

NANJING LEGEND BIOTECH CO., LTD.

NO. 6 BUILDING OF NANJING LIFE SCIENCE

Entity Type: 03

Trademark Details

Filing Date

September 26, 2018

Registration Date

October 22, 2019

Published for Opposition

August 6, 2019

Cancellation Date

May 8, 2026

Goods & Services

Medical clinic services; medical assistance; telemedicine services; medical, physical rehabilitation and physical therapy services; preparation of prescriptions by pharmacists; hospital services; health care; medical and pharmaceutical consultation; nursing, medical; veterinary services

Technical research in the field of pharmaceutical studies; consulting services for others in the field of design, planning, and implementation project management of scientific research; research and development of new products for others; scientific laboratory services; chemical analysis; chemistry consultation; chemical research; bacteriological research; biological research

Pharmaceutical preparations for treating multiple myeloma, blood cancer and solid tumor; chemico-pharmaceutical preparations for treating multiple myeloma, blood cancer and solid tumor; drugs for medical purposes for treating multiple myeloma, blood cancer and solid tumor; serotherapeutic medicines; biological preparations for medical purposes for treating multiple myeloma, blood cancer and solid tumor; chemical preparations for pharmaceutical purposes for treating multiple myeloma, blood cancer and solid tumor; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical drug for treating multiple myeloma, blood cancer and solid tumor; blood products, namely, blood plasma

Filing History

CANCELLED SECTION 71
May 8, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 22, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Apr 20, 2024 CHLD
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 15, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 15, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 15, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 15, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 15, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 14, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 14, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2019 NONP
ASSIGNED TO LIE
Jul 1, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2019 TROA
REFUSAL PROCESSED BY IB
May 18, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 30, 2019 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 6, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 5, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 4, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 2, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 27, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 21, 2019 REPR

Related Trademarks